Atreca (FRA:0C1) Current Deferred Taxes Liabilities : €0.00 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Atreca Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Atreca's current deferred tax liabilities for the quarter that ended in Sep. 2023 was €0.00 Mil.

Atreca Current Deferred Taxes Liabilities Historical Data

The historical data trend for Atreca's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atreca Current Deferred Taxes Liabilities Chart

Atreca Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Atreca Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Atreca Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Atreca's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Atreca (FRA:0C1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atreca Inc (FRA:0C1) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

BCEL:USA 0C1:Germany

Address

835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070

Website

https://www.atreca.com

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Atreca (FRA:0C1) Headlines

No Headlines